Crotalidae polyvalent immune Fab

Last updated
Crotalidae polyvalent immune Fab
Clinical data
Trade names CroFab
AHFS/Drugs.com Micromedex Detailed Consumer Information
Identifiers
CAS Number
ChemSpider
  • none
ChEMBL
 X mark.svgNYes check.svgY  (what is this?)    (verify)

Crotalidae polyvalent immune Fab (ovine), sold under the brandname CroFab, is a snake antivenin, indicated for North American crotalid (rattlesnake, copperhead and cottonmouth/water moccasin) snake envenomation. [1]

Contents

CroFab is composed of several monovalent Fab (fragment antigen-binding) proteins derived from the blood of sheep immunized with one of four snake venoms: Crotalus atrox (western diamondback rattlesnake), Crotalus adamanteus (Eastern diamondback rattlesnake), Crotalus scutulatus (Mojave rattlesnake), or Agkistrodon piscivorus (cottonmouth or water moccasin). Each monospecific antivenin is purified from sheep serum, digested with the enzyme papain, and purified further, resulting in specific Fab fragments. The resulting four different Fab preparations are mixed to formulate the final product. [2]

Background

The production technology was invented by Drs. John Sullivan and Findlay Russell, [3] developed clinically via multicenter clinical trials in the United States [4] and commercialized by BTG Limited (formerly Protherics PLC). As reported in the Washington Post in July 2015, this was the only commercially available antivenin in the United States for the treatment of venomous snakebites until the release of a competing product, Anavip. [5]

Treatment

Crotalid snakebites can range from mild to life-threatening, depending on the size and type of snake, the amount of venom injected and the location of the bite. This in turn determines the number of vials of CroFab that are required by the patient. Untreated, the snake venom can cause severe pain and tissue damage that can result in the loss of a limb or even death. Prompt (within six hours of snake bite) treatment with CroFab is recommended.

Adverse events

The most common adverse events reported in clinical studies were mild or moderate reactions involving the skin and appendages (primarily urticaria, rash, or pruritus), which occurred in 14 out of 42 patients. Three patients experienced a serious adverse event. Two patients had a severe allergic reaction (severe hives and a severe rash and pruritus) following treatment. One patient had a recurrent coagulopathy due to envenomation, which required re-hospitalisation and additional antivenin administration. In clinical trials, recurrent coagulopathy (the return of a coagulation abnormality after it has been successfully treated with antivenin), characterised by decreased fibrinogen, decreased platelets and elevated prothrombin time, occurred in approximately half of the patients studied. Recurrent coagulopathy may persist for one to two weeks or more. One patient discontinued CroFab therapy due to an allergic reaction. Patients with allergies to papain, chymopapain, other papaya extracts or the pineapple enzyme bromelain may also be at risk for an allergic reaction to CroFab. [6]

Cost

Leslie Boyer, director of the VIPER Institute and a member of the team that developed CroFab, collected data on the cost of production and marketing, and found that the largest true cost to payers in the United States was that of the legal, regulatory and hospital activities involved in selling the drug, nearly 75% of the total. Clinical trials contributed less than 10% of the cost, and 25% of that had been paid for by government grants. Other costs were the same as in Mexico. [7] [5]

Related Research Articles

<span class="mw-page-title-main">Eastern copperhead</span> Species of reptile

The eastern copperhead, also known simply as the copperhead, is a species of venomous snake, a pit viper, endemic to eastern North America; it is a member of the subfamily Crotalinae in the family Viperidae.

<i>Crotalus cerastes</i> Species of snake

Crotalus cerastes, known as the sidewinder, horned rattlesnake or sidewinder rattlesnake, is a pit viper species belonging to the genus Crotalus, and is found in the desert regions of the Southwestern United States and northwestern Mexico. Like all other pit vipers, it is venomous. Three subspecies are currently recognized.

<span class="mw-page-title-main">Antivenom</span> Medical treatment for venomous bites and stings

Antivenom, also known as antivenin, venom antiserum, and antivenom immunoglobulin, is a specific treatment for envenomation. It is composed of antibodies and used to treat certain venomous bites and stings. Antivenoms are recommended only if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

<span class="mw-page-title-main">Snakebite</span> Injury caused by bite from snakes

A snakebite is an injury caused by the bite of a snake, especially a venomous snake. A common sign of a bite from a venomous snake is the presence of two puncture wounds from the animal's fangs. Sometimes venom injection from the bite may occur. This may result in redness, swelling, and severe pain at the area, which may take up to an hour to appear. Vomiting, blurred vision, tingling of the limbs, and sweating may result. Most bites are on the hands, arms, or legs. Fear following a bite is common with symptoms of a racing heart and feeling faint. The venom may cause bleeding, kidney failure, a severe allergic reaction, tissue death around the bite, or breathing problems. Bites may result in the loss of a limb or other chronic problems or even death.

<span class="mw-page-title-main">Inland taipan</span> Highly venomous snake native to Australia

The inland taipan, also commonly known as the western taipan, small-scaled snake, or fierce snake, is a species of extremely venomous snake in the family Elapidae. The species is endemic to semiarid regions of central east Australia. Aboriginal Australians living in those regions named the snake dandarabilla. It was formally described by Frederick McCoy in 1879 and then by William John Macleay in 1882, but for the next 90 years, it was a mystery to the scientific community; no further specimens were found, and virtually nothing was added to the knowledge of this species until its rediscovery in 1972.

<span class="mw-page-title-main">Envenomation</span> Process of venom injection

Envenomation is the process by which venom is injected by the bite or sting of a venomous animal.

<i>Crotalus scutulatus</i> Species of snake

Crotalus scutulatus is known commonly as the Mohave Rattlesnake. Other common English names include Mojave Rattlesnake and, referring specifically to the nominate (northern) subspecies: Northern Mohave Rattlesnake and Mojave Green Rattlesnake, the latter name commonly shortened to the more colloquial “Mojave green”. Campbell and Lamar (2004) supported the English name “Mohave (Mojave) rattlesnake” with some reluctance because so little of the snake’s range lies within the Mojave Desert.

<span class="mw-page-title-main">Indian cobra</span> Species of snake

The Indian cobra, also known commonly as the spectacled cobra, Asian cobra, or binocellate cobra, is a species of cobra, a venomous snake in the family Elapidae. The species is native to the Indian subcontinent, and is a member of the "big four" species that are responsible for the most snakebite cases in India.

<i>Crotalus lepidus</i> Species of snake

Crotalus lepidus is a venomous pit viper species found in the southwestern United States and northern central Mexico. Four subspecies are currently recognized, including the nominate subspecies described here.

<i>Crotalus basiliscus</i> Species of reptile

Crotalus basiliscus, known as the Mexican west coast rattlesnake, Mexican green rattler, and also by other names, is a species of pit viper in the family Viperidae. The species is endemic to western Mexico. Like all other pit vipers, it is venomous. The specific name, basiliscus, is derived from the Greek word for king, βασιλισκος, and alludes to this snake's large size and potent venom. No subspecies are currently recognized.

<i>Crotalus helleri</i> Species of snake

Crotalus helleri or Crotalus oreganus helleri, also known commonly as the Southern Pacific rattlesnake, the black diamond rattlesnake, and by several other common names, is a pit viper species or subspecies found in southwestern California and south into Baja California, Mexico, that is known for its regional variety of dangerous venom types. It is sometimes considered a subspecies of Crotalus oreganus.

<span class="mw-page-title-main">Fragment antigen-binding region</span> Part of an antibody that binds to antigens

The fragment antigen-binding region is a region on an antibody that binds to antigens. It is composed of one constant and one variable domain of each of the heavy and the light chain. The variable domain contains the paratope, comprising a set of complementarity-determining regions, at the amino terminal end of the monomer. Each arm of the Y thus binds an epitope on the antigen.

<i>Agkistrodon contortrix phaeogaster</i> Subspecies of snake

Agkistrodon contortrix phaeogaster was formerly a venomous pit viper subspecies found in the central region of the United States. However, recent taxonomic changes do not recognize the Osage copperhead as a valid taxon.

<i>Crotalus concolor</i> Species of snake

Crotalus concolor, commonly known as the midget faded rattlesnake, faded rattlesnake, and yellow rattlesnake, is a pit viper species found in the western United States. It is a small rattlesnake known for its faded color pattern. Like all other pit vipers, it is venomous.

Venom-induced consumption coagulopathy (VICC) is a medical condition caused by the effects of some snake and caterpillar venoms on the blood. Important coagulation factors are activated by the specific serine proteases in the venom and as they become exhausted, coagulopathy develops. Symptoms are consistent with uncontrolled bleeding. Diagnosis is made using blood tests that assess clotting ability along with recent history of envenomation. Treatment generally involves pressure dressing, confirmatory blood testing, and antivenom administration.

Snake antivenom is a medication made up of antibodies used to treat snake bites by venomous snakes. It is a type of antivenom.

<span class="mw-page-title-main">Epidemiology of snakebites</span>

Most snakebites are caused by non-venomous snakes. Of the roughly 3,700 known species of snake found worldwide, only 15% are considered dangerous to humans. Snakes are found on every continent except Antarctica. There are two major families of venomous snakes, Elapidae and Viperidae. 325 species in 61 genera are recognized in the family Elapidae and 224 species in 22 genera are recognized in the family Viperidae, In addition, the most diverse and widely distributed snake family, the colubrids, has approximately 700 venomous species, but only five genera—boomslangs, twig snakes, keelback snakes, green snakes, and slender snakes—have caused human fatalities.

Findlay Ewing Russell was an American internal medicine physician and toxicologist. He pursued a research interest in venomous and poisonous animals and the effects of toxins on the human nervous system and was widely acknowledged as one of the world's leading authorities on snakes and the pharmacology of snake venoms. Consulting work for the United Nations and various governmental agencies took him all over the world.

<span class="mw-page-title-main">Steven Seifert</span> American medical toxicologist

Steven A. Seifert (1950–2022) was an American medical toxicologist. He was a professor of emergency medicine at the University of New Mexico, as well as the medical director of the New Mexico Poison and Drug Information Center. Since 2017, he was the editor-in-chief of Clinical Toxicology. He was also a jazz tenor saxophonist.

References

  1. "CroFab | Copperhead, Cottonmouth, and Rattlesnake Antivenom | CroFab.com". crofab.com. Retrieved 2023-05-23.
  2. "Notice Regarding Change in Version of CROFAB (Crotalidae Polyvalent FAB (Ovine)) Prescribing Information" (PDF). CroFab-Prescribing-Information. BTG International Inc. Retrieved 17 August 2020.
  3. US8048414B1,Sullivan, John B.&Russell, Findlay E.,"Antivenom composition containing Fab fragments",issued 2011-11-01
  4. Dart RC, Seifert SA, Boyer LV, Clark RF, Hall E, McKinney P, et al. (September 2001). "A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States". Archives of Internal Medicine. 161 (16): 2030–2036. doi:10.1001/archinte.161.16.2030. PMID   11525706.
  5. 1 2 Ingraham C (20 July 2015). "This $153,000 rattlesnake bite is everything wrong with American health care". The Washington Post.
  6. "Treatment with CroFab". BTG Specialty Pharmaceuticals. Retrieved 18 June 2015.
  7. Boyer LV (December 2015). "On 1000-Fold Pharmaceutical Price Markups and Why Drugs Cost More in the United States than in Mexico". The American Journal of Medicine. 128 (12): 1265–1267. doi: 10.1016/j.amjmed.2015.08.007 . PMID   26302139. S2CID   45007792.